Canadian Agency for Drugs and Technologies in Health
Impact in
-
- Meta-analysis and systematic reviews
Papers in
-
- Meta-analysis and systematic reviews 23
-
- Health Systems, Economic Evaluations, Quality of Life 80
- Pharmaceutical Economics and Policy 14
- Economic and Financial Impacts of Cancer 11
- Healthcare Policy and Management 8
- Top scholars
- Julie PolisenaKaren CimonKhai TranTammy CliffordVijay K. ShuklaMelissa SevernDoug CoyleJohn Conly
- Journals
- International Journal of Technology Assessment in Health Care (39 papers)Value in Health (16 papers)Systematic Reviews (10 papers)Cochrane Database of Systematic Reviews (10 papers)Journal of Clinical Epidemiology (10 papers)
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
Canadian Agency for Drugs and Technologies in Health
238 papers receiving 13.6k citations
Peers
Comparison fields: 5 of 207
- Statistics, Probability and Uncertainty 950
- Internal Medicine 300
- Orthopedics and Sports Medicine 733
- General Health Professions 1.7k
- Economics and Econometrics 2.0k
Countries citing scholars working at Canadian Agency for Drugs and Technologies in Health
This map shows the geographic impact of research produced by authors working at Canadian Agency for Drugs and Technologies in Health. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Canadian Agency for Drugs and Technologies in Health with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Canadian Agency for Drugs and Technologies in Health more than expected).
Fields of papers published by authors at Canadian Agency for Drugs and Technologies in Health
This network shows the impact of papers affiliated with Canadian Agency for Drugs and Technologies in Health at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Canadian Agency for Drugs and Technologies in Health at the time of their publication.
About Canadian Agency for Drugs and Technologies in Health
In recent decades, authors affiliated with Canadian Agency for Drugs and Technologies in Health have published 329 papers, which have received a total of 19.6k indexed citations . Scholars at this organization have produced 24 papers in Statistics, Probability and Uncertainty, 86 papers in Economics and Econometrics, 45 papers in General Health Professions, 2 papers in Health Informatics and 2 papers in Medical Laboratory Technology on the topics of Health Systems, Economic Evaluations, Quality of Life (80 papers), Meta-analysis and systematic reviews (23 papers), Healthcare cost, quality, practices (19 papers), Pharmaceutical Economics and Policy (14 papers), Economic and Financial Impacts of Cancer (11 papers), Biomedical Ethics and Regulation (8 papers), Mental Health and Patient Involvement (8 papers) and Healthcare Policy and Management (8 papers). Their work is cited by papers focused on Statistics, Probability and Uncertainty (950 citations), Internal Medicine (300 citations), Orthopedics and Sports Medicine (733 citations), General Health Professions (1.7k citations) and Economics and Econometrics (2.0k citations). Authors at Canadian Agency for Drugs and Technologies in Health collaborate with scholars in Canada, United States and United Kingdom and have published in prestigious journals including International Journal of Technology Assessment in Health Care, Value in Health, Systematic Reviews, Cochrane Database of Systematic Reviews and Journal of Clinical Epidemiology. Some of Canadian Agency for Drugs and Technologies in Health's most productive authors include Julie Polisena, Karen Cimon, Khai Tran, Tammy Clifford, Vijay K. Shukla, Melissa Severn, Doug Coyle, John Conly, Carmem L Pessoa-Silva and Susan L. Norris.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.